Gemcitabine and docetaxel combination chemotherapy for advanced bone and soft tissue sarcomas: protocol for an open-label, non-randomised, Phase 2 study

BACKGROUND: The prognosis of patients with metastatic or advanced sarcomas is poor and there are few options for treatment. Several studies have shown that gemcitabine and docetaxel (GD) combination chemotherapy has antitumor activity against various subtypes of sarcoma. Recently, some studies have...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:BMC Cancer
Egile Nagusiak: Hara, Hitomi, Kawamoto, Teruya, Fukase, Naomasa, Kawakami, Yohei, Takemori, Toshiyuki, Fujiwara, Shuichi, Kitayama, Kazumichi, Nishida, Kotaro, Kuroda, Ryosuke, Akisue, Toshihiro
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: BioMed Central 2019
Gaiak:
Study Protocol
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6651911/
https://ncbi.nlm.nih.gov/pubmed/31337342
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-019-5923-7
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak